National Institute on Aging; Notice of Closed Meetings, 96022-96023 [2016-31566]
Download as PDF
96022
Federal Register / Vol. 81, No. 250 / Thursday, December 29, 2016 / Notices
Place: Conference Room 6C6, Building 31,
National Institutes of Health, Bethesda, MD
20892.
Contact Person: Gretchen Wood, Staff
Assistant, National Institutes of Health,
Office of the Director, One Center Drive,
Building 1 Room 126, Bethesda, MD 20892,
301–496–4272, woodgs@od.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Dated: December 23, 2016.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–31611 Filed 12–28–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Microbiology,
Infectious Diseases and AIDS Initial Review
Group Microbiology and Infectious Diseases
Research Committee.
Date: January 26–27, 2017.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Frank S. De Silva, Ph.D.,
Scientific Review Officer, Scientific Review
VerDate Sep<11>2014
18:41 Dec 28, 2016
Jkt 241001
Program, Division of Extramural Activities,
Room #3E72A, National Institutes of Health/
NIAID, 5601 Fishers Lane, MSC 9834,
Bethesda, MD 20892934, (240) 669–5023,
fdesilva@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: December 23, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–31568 Filed 12–28–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Initial Review Group; Neuroscience of
Aging Review Committee.
Date: February 2–3, 2017.
Time: 3:00 p.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Jeannette L. Johnson,
Ph.D., Deputy Review Branch Chief, National
Institutes of Health, National Institute on
Aging, Gateway Building, Bethesda, MD
20892, 301–402–7705, johnsonj9@
nia.nih.gov.
Name of Committee: National Institute on
Aging Initial Review Group; Behavior and
Social Science of Aging Review Committee.
Date: February 2–3, 2017.
Time: 3:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Kimberly Firth, Ph.D.,
National Institute on Aging, Gateway
Building, 7201 Wisconsin Avenue, Suite
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
2C212, Bethesda, MD 20892, 301–402–7702,
kimberly.firth@nih.gov.
Name of Committee: National Institute on
Aging Initial Review Group; Biological Aging
Review Committee.
Date: February 2–3, 2017.
Time: 4:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Bita Nakhai, Ph.D.,
Scientific Review Branch, National Institute
on Aging, Gateway Bldg., 2C212, 7201
Wisconsin Avenue, Bethesda, MD 20814,
301–402–7701, nakhaib@nia.nih.gov.
Name of Committee: National Institute on
Aging Initial Review Group; Clinical Aging
Review Committee.
Date: February 2–3, 2017.
Time: 4:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Alicja L. Markowska,
Ph.D., D.Sc., National Institute on Aging,
National Institutes of Health, Gateway
Building 2C212, 7201 Wisconsin Avenue,
Bethesda, MD 20892, 301–496–9666,
markowsa@nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: December 22, 2016.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–31433 Filed 12–28–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; P30 and P50
Revisions for AD Centers.
E:\FR\FM\29DEN1.SGM
29DEN1
Federal Register / Vol. 81, No. 250 / Thursday, December 29, 2016 / Notices
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Date: February 13, 2017.
Time: 12:01 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, Suite 2W200, 7201
Wisconsin Ave., Bethesda, MD 20892.
Contact Person: Maurizio Grimaldi, MD,
Ph.D., Scientific Review Officer, National
Institute on Aging, National Institutes of
Health, 7201 Wisconsin Avenue, Room
2C218, Bethesda, MD 20892, 301–496–9374,
grimaldim2@mail.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel; 2017 Beeson
Review.
Date: February 24, 2017.
Time: 11:00 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, Suite 2W200, 7201
Wisconsin Avenue, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Alexander Parsadanian,
Ph.D., Scientific Review Officer, National
Institute on Aging, Gateway Building 2C/212,
7201 Wisconsin Avenue, Bethesda, MD
20892, 301–496–9666, Parsadaniana@
nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
and incorporated under the laws of
Delaware.
DATES: Only written comments and/or
applications for a license which are
received by the NHLBI Office of
Technology Transfer and Development
on or before January 13, 2017 will be
considered.
ADDRESSES: Requests for copies of the
patent application, inquiries, and
comments relating to the contemplated
exclusive license should be directed to:
Cristina Thalhammer-Reyero, Ph.D.,
MBA, Senior Licensing and Patenting
Manager, NHLBI Office of Technology
Transfer and Development, 31 Center
Drive Room 4A29, MSC2479, Bethesda,
MD 20892–2479; Telephone: +1–301–
435–4507; Fax: +1–301–594–3080;
Email: thalhamc@mail.nih.gov.
SUPPLEMENTARY INFORMATION: The
following represents the intellectual
property to be licensed under the
prospective agreement:
PCT Application Number: PCT/
US2004/21985, filed 9 July 2004, and
corresponding US, EP, CA, AU and JP
filings; and PCT Patent Application
PCT/US2004/22232 filed 9 July 2004,
and corresponding issued patents in EP,
Dated: December 23, 2016.
CA, AU and JP, as well as US 8,927,030
Melanie J. Pantoja,
issued 01/06/2015; US 9,387,224 issued
Program Analyst, Office of Federal Advisory
07/12/2016, and two pending US patent
Committee Policy.
applications; Titled ‘‘Use of Nitrite Salts
[FR Doc. 2016–31566 Filed 12–28–16; 8:45 am]
for the treatment of Cardiovascular
BILLING CODE 4140–01–P
Conditions’’ (NIH Reference No. E–254–
2003/0,1,2,3)
With respect to persons who have an
DEPARTMENT OF HEALTH AND
obligation to assign their right, title and
HUMAN SERVICES
interest to the Government of the United
States of America, the patent rights in
National Institutes of Health
these inventions have been assigned to
the Government of the United States of
Prospective Grant of Exclusive Patent
America.
License: Development and
The prospective exclusive license
Commercialization of Nitrite Salts for
territory may be worldwide and the
the Treatment, Amelioration, and
field of use may be limited to: ‘‘Use of
Prevention by Any Route of
the Licensed Patent Rights for the
Administration of Pulmonary
treatment, amelioration, and prevention
Hypertension, Including All WHO
of any kind or nature and by any route
Classifications of Pulmonary
of administration of Pulmonary
Hypertension, e.g., Groups 1–5
Hypertension, including all WHO
classifications of pulmonary
AGENCY: National Institutes of Health,
hypertension, e.g., Groups 1–5’’.
HHS.
The invention pertains to the
ACTION: Notice.
unexpected finding that low,
SUMMARY: The National Heart, Lung, and physiological and non-toxic
Blood Institute (‘‘NHLBI’’), an institute
concentrations of sodium nitrite are able
of the National Institutes of Health; an
to increase blood flow and produce
agency within the Department of Health vasodilation by infused and nebulized
and Human Services, is contemplating
routes of administration.
This notice is made in accordance
the grant of an exclusive patent license
with 35 U.S.C. 209 and 37 CFR part 404.
to commercialize the invention(s)
The prospective Exclusive Patent
embodied in the intellectual property
License will be royalty bearing and may
estate stated in the Summary
be granted unless within fifteen (15)
Information section of this notice to
days from the date of this published
United Therapeutics Corporation
(‘‘United’’) located in Silver Spring, MD notice, the NHLBI Office of Technology
VerDate Sep<11>2014
18:41 Dec 28, 2016
Jkt 241001
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
96023
Transfer and Development receives
written evidence and argument that
establishes that the grant of the license
would not be consistent with the
requirements of 35 U.S.C. 209 and 37
CFR part 404.
Complete applications for a license in
the prospective field of use that are
timely filed in response to this notice
will be treated as objections to the grant
of the contemplated Exclusive Patent
License. Comments and objections to
this notice submitted will not be made
available for public inspection and, to
the extent permitted by law, will not be
released under the Freedom of
Information Act, 5 U.S.C. 552.
Dated: December 21, 2016.
Cristina Thalhammer-Reyero,
Senior Licensing and Patenting Manager,
Office of Technology Transfer and
Development, National Heart, Lung, and
Blood Institute.
[FR Doc. 2016–31437 Filed 12–28–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary
and Integrative Health; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Council for
Complementary and Integrative Health.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council for Complementary and Integrative
Health.
Date: February 3, 2017.
Closed: 8:30 a.m. to 9:15 a.m.
E:\FR\FM\29DEN1.SGM
29DEN1
Agencies
[Federal Register Volume 81, Number 250 (Thursday, December 29, 2016)]
[Notices]
[Pages 96022-96023]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-31566]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Aging Special Emphasis
Panel; P30 and P50 Revisions for AD Centers.
[[Page 96023]]
Date: February 13, 2017.
Time: 12:01 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Aging, Gateway Building, Suite
2W200, 7201 Wisconsin Ave., Bethesda, MD 20892.
Contact Person: Maurizio Grimaldi, MD, Ph.D., Scientific Review
Officer, National Institute on Aging, National Institutes of Health,
7201 Wisconsin Avenue, Room 2C218, Bethesda, MD 20892, 301-496-9374,
grimaldim2@mail.nih.gov.
Name of Committee: National Institute on Aging Special Emphasis
Panel; 2017 Beeson Review.
Date: February 24, 2017.
Time: 11:00 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Aging, Gateway Building, Suite
2W200, 7201 Wisconsin Avenue, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Alexander Parsadanian, Ph.D., Scientific Review
Officer, National Institute on Aging, Gateway Building 2C/212, 7201
Wisconsin Avenue, Bethesda, MD 20892, 301-496-9666,
Parsadaniana@nia.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging
Research, National Institutes of Health, HHS)
Dated: December 23, 2016.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-31566 Filed 12-28-16; 8:45 am]
BILLING CODE 4140-01-P